All Stories

  1. Pre-infusion quantitative EEG features associated with delayed neurocognitive impairment following CAR T-cell therapy

    Article • Journal of Neuroimmunology, October 2026, Elsevier

    Dr Pedro Jesus Serrano-Castro

  2. Implementación del Código Crisis para la atención urgente de la epilepsia en España: un protocolo asistencial integral

    Article • Revista Kranion, April 2026, Publicidad Permanyer, SLU

    Dr Pedro Jesus Serrano-Castro

  3. Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real‐world clinical practice

    Article • Epileptic Disorders, March 2026, Wiley

    Dr Pedro Jesus Serrano-Castro

  4. Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation

    Article • Nutrients, January 2026, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  5. Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour

    Article • Journal of Psychopharmacology, November 2025, SAGE Publications

    Dr Pedro Jesus Serrano-Castro

  6. Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World Study

    Article • Neurology and Therapy, November 2025, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  7. Prior restraint stress counteracts memory deficits associated with adolescent alcohol exposure by targeting both the hippocampal endocannabinoid and glutamatergic systems

    Article • Drug and Alcohol Dependence, November 2025, Elsevier

    Dr Pedro Jesus Serrano-Castro

  8. Early Oral Administration of D-Chiro-Inositol Reverses Hippocampal Insulin and Glutamate Signaling Deficits in the 3×Tg Humanized Mouse Model of Alzheimer’s Disease

    Article • Nutrients, September 2025, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  9. Late-onset Rasmussen encephalitis: 3 illustrative cases and a review of the literature

    Article • Neurología, September 2025, Elsevier

    Dr Pedro Jesus Serrano-Castro

  10. Effectiveness and safety of early add‐on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV‐add study

    Article • Epilepsia Open, August 2025, Wiley

    Dr Pedro Jesus Serrano-Castro

  11. Cataract Surgery in Cognitive Impairment: Navigating the Accessibility Challenge in European Healthcare

    Article • Ophthalmology and Therapy, August 2025, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  12. Tratamiento de la crisis epiléptica en el ámbito no sanitario: tiempo de tratar (TT)

    Article • Medicina Clínica, August 2025, Elsevier

    Dr Pedro Jesus Serrano-Castro

  13. Peripheral expression of NPY1R-based heteroreceptor complexes reflects hippocampal neuroimmune status: Novel biomarkers for early Alzheimer’s disease detection

    Article • Biomedicine & Pharmacotherapy, August 2025, Elsevier

    Dr Pedro Jesus Serrano-Castro

  14. Relapses in Anti-NMDAR Encephalitis

    Article • Neurology Neuroimmunology & Neuroinflammation, July 2025, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  15. Inflammatory Drug-Resistant Epilepsy Index (IDREI) as a Molecular Compound Biomarker in Focal Epilepsies

    Article • Biomolecules, June 2025, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  16. Proposal of an Inflammatory Drug‐Resistant Epilepsy Index (Idrei) as Molecular Composed Biomarker in Focal Epilepsies

    Article • May 2025, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  17. Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis

    Article • Frontiers in Medicine, April 2025, Frontiers

    Dr Pedro Jesus Serrano-Castro, Professor Antonio Fernandez-Nebro

  18. Interim analysis of the long‐term efficacy and safety of azetukalner in an ongoing open‐label extension study following a phase 2b clinical trial (X‐TOLE) in adults with focal epilepsy

    Article • Epilepsia Open, March 2025, Wiley

    Dr Pedro Jesus Serrano-Castro

  19. Blood levels of cytokines highlight the role of inflammation in Alzheimer's disease

    Article • Heliyon, January 2025, Elsevier

    Dr Pedro Jesus Serrano-Castro

  20. Recombinant soluble type I interferon receptor exerts antiviral activity by inducing proteins related to autophagy

    Article • Biomedicine & Pharmacotherapy, December 2024, Elsevier

    Dr Pedro Jesus Serrano-Castro

  21. Perceptions of key informant neurologists before implementing anti-amyloid drugs in the Spanish departments of neurology

    Article • Journal of Alzheimer’s Disease, November 2024, SAGE Publications

    Dr Pedro Jesus Serrano-Castro

  22. Design and validation of a questionnaire for monitoring neurological dysphagia and respiratory deterioration in patients with amyotrophic lateral sclerosis (DEREDELA)

    Article • Neurología (English Edition), October 2024, Elsevier

    Dr Pedro Jesus Serrano-Castro

  23. Pronóstico funcional de pacientes con NORSE y FIRES tratados con inmunoterapia: revisión sistemática

    Article • Neurología, October 2024, Elsevier

    Dr Pedro Jesus Serrano-Castro

  24. A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis

    Article • International Journal of Molecular Sciences, June 2024, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  25. Impact of inflammation on cognitive function in patients with highly inflammatory rheumatoid arthritis

    Article • RMD Open, June 2024, BMJ

    Professor Antonio Fernandez-Nebro, Dr Pedro Jesus Serrano-Castro

  26. Biomarkers of Neuroinflammation and Epileptogenesis: A Systematic Review

    Article • May 2024, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  27. Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats

    Article • Cells, April 2024, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  28. Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus

    Article • The FASEB Journal, April 2024, Wiley

    Dr Pedro Jesus Serrano-Castro, Professor Kjell Fuxe

  29. Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder

    Article • Expert Opinion on Therapeutic Targets, April 2024, Taylor & Francis

    Dr Pedro Jesus Serrano-Castro

  30. Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus

    Article • Expert Opinion on Therapeutic Targets, April 2024, Taylor & Francis

    Dr Pedro Jesus Serrano-Castro

  31. Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions

    Article • Behavioral and Brain Functions, March 2024, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  32. Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study

    Article • Toxics, February 2024, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  33. Neuropeptide Y receptor 1 and galanin receptor 2 (NPY1R-GALR2) interactions in the dentate gyrus and their relevance for neurogenesis and cognition

    Article • Frontiers in Cellular Neuroscience, February 2024, Frontiers

    Dr Pedro Jesus Serrano-Castro

  34. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study

    Article • CNS Drugs, January 2024, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  35. Epileptic and neurodevelopmental encephalopathy associated to SYNGAP1 mutation: Description of a case and treatment response to cannabidiol

    Article • Neurología (English Edition), January 2024, Elsevier

    Dr Pedro Jesus Serrano-Castro

  36. Encefalopatía epiléptica y del desarrollo asociada a mutación del SYNGAP1: descripción de un caso y respuesta al tratamiento con cannabidiol

    Article • Neurología, January 2024, Elsevier

    Dr Pedro Jesus Serrano-Castro

  37. Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy

    Article • JAMA Neurology, November 2023, American Medical Association (AMA)

    Dr Pedro Jesus Serrano-Castro

  38. Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies

    Article • Neurology Neuroimmunology & Neuroinflammation, November 2023, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  39. Comparing RNA extraction methods to face the variations in RNA quality using two human biological matrices

    Article • Molecular Biology Reports, October 2023, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  40. Environmental exposure to pesticides and Amyotrophic Lateral Sclerosis in the South of Spain

    Article • Neurología (English Edition), September 2023, Elsevier

    Dr Pedro Jesus Serrano-Castro

  41. Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations

    Article • Frontiers in Immunology, August 2023, Frontiers

    Dr Pedro Jesus Serrano-Castro

  42. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis

    Article • Neurology Neuroimmunology & Neuroinflammation, July 2023, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  43. Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Article • Epilepsia Open, May 2023, Wiley

    Dr Pedro Jesus Serrano-Castro

  44. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  45. Comparing RNA extraction methods to face the variations in RNA quality using two human biological matrices

    Article • December 2022, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  46. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Article • Epilepsy & Behavior, December 2022, Elsevier

    Dr Pedro Jesus Serrano-Castro

  47. Functional outcomes of patients with NORSE and FIRES treated with immunotherapy: A systematic review

    Article • Neurología (English Edition), September 2022, Elsevier

    Dr Pedro Jesus Serrano-Castro

  48. Longitudinal Study of Cognitive Functioning in Adults with Juvenile Idiopathic Arthritis

    Article • Biomedicines, July 2022, MDPI AG

    Dr Pedro Jesus Serrano-Castro, Professor Antonio Fernandez-Nebro

  49. Design and validation of a questionnaire for monitoring neurological dysphagia and respiratory deterioration in patients with amyotrophic lateral sclerosis (DEREDELA)

    Article • Neurología, June 2022, Elsevier

    Dr Pedro Jesus Serrano-Castro

  50. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) in a patient with Crohn's disease on anti-TNF treatment

    Article • Neurología (English Edition), May 2022, Elsevier

    Dr Pedro Jesus Serrano-Castro

  51. Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies

    Article • Biomedicines, March 2022, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  52. The cognitive and psychiatric subacute impairment in severe Covid-19

    Article • Scientific Reports, March 2022, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  53. Fracaso de un anticuerpo monoclonal anti-CGRP en el tratamiento de la migraña. ¿Tiene sentido probar otro?

    Article • Revista de Neurología, January 2022, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  54. Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis

    Article • International Journal of Molecular Sciences, December 2021, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  55. The Cognitive and Psychiatric Subacute Impairment in severe Covid-19.

    Article • November 2021, Research Square

    Dr Pedro Jesus Serrano-Castro

  56. Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with Drug-Resistant Temporal Lobe Epilepsy of Unknown Etiology

    Article • Journal of Clinical Medicine, October 2021, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  57. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA)

    Article • Epilepsy & Behavior, September 2021, Elsevier

    Dr Pedro Jesus Serrano-Castro

  58. The Cognitive and Psychiatric Subacute Impairment in severe Covid-19.

    Article • August 2021, Research Square

    Dr Pedro Jesus Serrano-Castro

  59. Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, August 2021, Taylor & Francis

    Dr Pedro Jesus Serrano-Castro

  60. Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain

    Article • Brain Structure and Function, July 2021, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  61. Efectos de la pandemia por Covid-19 sobre la calidad de vida de los pacientes con Esclerosis Lateral Amiotrófica

    Article • Enfermería Global, July 2021, Servicio de Publicaciones de la Universidad de Murcia

    Dr Pedro Jesus Serrano-Castro

  62. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) in a patient with Crohn's disease on anti-TNF treatment

    Article • Neurología, July 2021, Elsevier

    Dr Pedro Jesus Serrano-Castro

  63. Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, June 2021, Elsevier

    Dr Pedro Jesus Serrano-Castro

  64. GABAergic deficits in absence of LPA1 receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the dorsal hippocampus

    Article • Brain Structure and Function, April 2021, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  65. Prevalence of Neural Autoantibodies in Epilepsy of Unknown Etiology: Systematic Review and Meta-Analysis

    Article • Brain Sciences, March 2021, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  66. Environmental exposure to pesticides and Amyotrophic Lateral Sclerosis in the South of Spain

    Article • Neurología, March 2021, Elsevier

    Dr Pedro Jesus Serrano-Castro

  67. Emergency implementation of telemedicine for epilepsy in Spain: Results of a survey during SARS-CoV-2 pandemic

    Article • Epilepsy & Behavior, October 2020, Elsevier

    Dr Pedro Jesus Serrano-Castro

  68. Miller‐Fisher syndrome after SARS‐CoV‐2 infection

    Article • European Journal of Neurology, August 2020, Wiley

    Dr Pedro Jesus Serrano-Castro

  69. The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases

    Article • Biomedicines, August 2020, MDPI AG

    Dr Pedro Jesus Serrano-Castro

  70. Reader response: Neurologic complications of coronavirus infections

    Article • Neurology, August 2020, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  71. Ofatumumab versus Teriflunomide in Multiple Sclerosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Pedro Jesus Serrano-Castro, Dr. Ron Milo, Professor Tjalf Ziemssen

  72. Neuroplasticity and Epilepsy Surgery in Brain Eloquent Areas: Case Report

    Article • Frontiers in Neurology, July 2020, Frontiers

    Dr Pedro Jesus Serrano-Castro

  73. Implantación emergente de un servicio de Teleneurología en la Unidad de Neuromuscular del Hospital Regional de Málaga durante la pandemia por SARS-CoV-2

    Article • Neurología, July 2020, Elsevier

    Dr Pedro Jesus Serrano-Castro

  74. Análisis de letalidad por COVID-19 en pacientes con demencia neurodegenerativa

    Article • Neurología, July 2020, Elsevier

    Dr Pedro Jesus Serrano-Castro

  75. Incidence and case fatality rate of COVID-19 in patients with active epilepsy

    Article • Neurology, June 2020, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  76. Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada?

    Article • Neurología, May 2020, Elsevier

    Dr Pedro Jesus Serrano-Castro

  77. ¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave

    Article • Neurología, May 2020, Elsevier

    Dr Pedro Jesus Serrano-Castro

  78. Response to immunotherapy in anti‐IgLON5 disease: A systematic review

    Article • Acta Neurologica Scandinavica, January 2020, Wiley

    Dr Pedro Jesus Serrano-Castro

  79. Evaluación prequirúrgica mediante resonancia magnética funcional en pacientes con tumores neuroepiteliales disembrioplásicos: una serie de casos

    Article • Neurocirugía, November 2019, Elsevier

    Dr Pedro Jesus Serrano-Castro

  80. Clinical outcomes of eslicarbazepine acetate monotherapy for focal‐onset seizures: A multicenter audit

    Article • Acta Neurologica Scandinavica, October 2019, Wiley

    Dr Pedro Jesus Serrano-Castro

  81. Epileptic encephalopathy with phenotype pseudo-Dravet and missense mutation in the GRIN2A gene

    Article • Clinica Chimica Acta, June 2019, Elsevier

    Dr Pedro Jesus Serrano-Castro

  82. Miastenia grave inducida por tratamiento con inhibidores del punto de control inmunológico: primer caso secundario a avelumab y revisión de casos previamente publicados

    Article • Revista de Neurología, January 2019, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  83. Factores asociados al mal control de la anticoagulación con antivitamina K en pacientes con fibrilación auricular no valvular atendidos en consultas de Medicina Interna y Neurología. Estudio ALADIN

    Article • Revista Clínica Española, October 2018, Elsevier

    Dr Pedro Jesus Serrano-Castro

  84. Consenso Delphi EPICON: recomendaciones sobre el manejo adecuado del cambio a acetato de eslicarbazepina en epilepsia

    Article • Neurología, June 2018, Elsevier

    Dr Pedro Jesus Serrano-Castro

  85. Efficacy of antiepileptic drugs in autoimmune epilepsy: A systematic review

    Article • Seizure, May 2018, Elsevier

    Dr Pedro Jesus Serrano-Castro

  86. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures

    Article • Acta Neurologica Scandinavica, March 2018, Wiley

    Dr Pedro Jesus Serrano-Castro

  87. Estudio observacional multicéntrico español sobre el empleo de fármacos antiepilépticos en consultas de neurología

    Article • Neurología, March 2018, Elsevier

    Dr Pedro Jesus Serrano-Castro

  88. Epidemiología de la epilepsia en España y Latinoamérica

    Article • Revista de Neurología, January 2018, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  89. Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients

    Article • Epilepsy Research, December 2017, Elsevier

    Dr Pedro Jesus Serrano-Castro

  90. Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway

    Article • Scientific Reports, November 2017, Nature

    Dr Pedro Jesus Serrano-Castro

  91. Awagrafia

    Article • Neurología, November 2017, Elsevier

    Dr Pedro Jesus Serrano-Castro

  92. Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment

    Article • Scientific Reports, August 2017, Nature

    Dr Pedro Jesus Serrano-Castro

  93. Recomendaciones para el abordaje multidisciplinar del complejo esclerosis tuberosa

    Article • Medicina Clínica, September 2016, Elsevier

    Dr Pedro Jesus Serrano-Castro

  94. Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study

    Article • Neurology and Therapy, April 2016, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  95. Adhesión al tratamiento con levetiracetam: estudio observacional retrospectivo no intervencionista

    Article • Revista de Neurología, January 2016, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  96. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial

    Article • Seizure, September 2015, Elsevier

    Dr Pedro Jesus Serrano-Castro

  97. Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: case report and brief review of the literature

    Article • International Journal of Clinical Pharmacy, March 2015, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  98. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

    Article • Annals of Neurology, January 2015, Wiley

    Dr Luisa M Villar, Dr Pedro Jesus Serrano-Castro

  99. Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study

    Article • The Scientific World JOURNAL, January 2015, Hindawi Publishing Corporation

    Dr Pedro Jesus Serrano-Castro

  100. Tratamiento combinado con fármacos antiepilépticos. Guía Andaluza de Epilepsia 2015

    Article • Revista de Neurología, January 2015, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  101. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Article • Clinical Drug Investigation, December 2014, Springer Science + Business Media

    Dr Pedro Jesus Serrano-Castro

  102. Analysis of Factors Influencing Telephone Call Response Rate in an Epidemiological Study

    Article • The Scientific World JOURNAL, January 2014, Hindawi Publishing Corporation

    Dr Pedro Jesus Serrano-Castro

  103. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide

    Article • Epilepsy & Behavior, November 2013, Elsevier

    Dr Pedro Jesus Serrano-Castro

  104. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

    Article • Vaccine, September 2013, Elsevier

    PhD Antonio Addis, Dr Pedro Jesus Serrano-Castro

  105. Characteristics of temporal lobe epilepsy with no ictal impairment of consciousness

    Article • Clinical Neurology and Neurosurgery, August 2013, Elsevier

    Dr Pedro Jesus Serrano-Castro

  106. Spatial recognition memory in a virtual reality task is altered in refractory temporal lobe epilepsy

    Article • Epilepsy & Behavior, August 2013, Elsevier

    Dr Pedro Jesus Serrano-Castro

  107. The expanding spectrum of febrile infection-related epilepsy syndrome (FIRES)

    Article • Seizure, March 2013, Elsevier

    Dr Pedro Jesus Serrano-Castro

  108. Validación en castellano de un cuestionario breve útil para cribado epidemiológico de epilepsia en España: Cuestionario EPIBERIA

    Article • Neurología, January 2013, Elsevier

    Dr Pedro Jesus Serrano-Castro

  109. Acetato de eslicarbazepina en la práctica clínica. Resultados de eficacia y seguridad

    Article • Revista de Neurología, January 2013, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  110. Zonisamida en el tratamiento de la epilepsia: revisión de la bibliografía desde la terapia añadida a la monoterapia

    Article • Revista de Neurología, January 2013, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  111. Consenso de las Recomendaciones de Actuación diagnóstica y Terapéutica sobre Epilepsia resistente a fármacos antiepilépticos en España (Consenso RATE-España)

    Article • Neurología, October 2012, Elsevier

    Dr Pedro Jesus Serrano-Castro

  112. Predictive model for refractoriness in Temporal Lobe Epilepsy based on clinical and diagnostic test data

    Article • Epilepsy Research, August 2012, Elsevier

    Dr Pedro Jesus Serrano-Castro

  113. Cajal’s first steps in scientific research

    Article • Neuroscience, August 2012, Elsevier

    Dr Pedro Jesus Serrano-Castro

  114. Spatial navigation impairment in patients with refractory temporal lobe epilepsy: Evidence from a new virtual reality-based task

    Article • Epilepsy & Behavior, October 2011, Elsevier

    Dr Pedro Jesus Serrano-Castro, Maria Dolores Roldán Tapia

  115. Factores vinculados a la adhesión al tratamiento en pacientes con epilepsia refractaria y no refractaria

    Article • Revista de Neurología, January 2011, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  116. Antiepileptic treatment in patients with epilepsy and other comorbidities

    Article • Seizure, September 2010, Elsevier

    Dr Pedro Jesus Serrano-Castro

  117. Vohwinkel Syndrome secondary to missense mutation D66H in GJB2 gene (connexin 26) can include epileptic manifestations

    Article • Seizure, March 2010, Elsevier

    Dr Pedro Jesus Serrano-Castro

  118. Amnesia topográfica transitoria: descripción de una serie de ocho casos

    Article • Revista de Neurología, January 2010, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  119. Possible case of peripheral osmotic demyelination syndrome

    Article • BMJ Case Reports, February 2009, BMJ

    Dr Pedro Jesus Serrano-Castro

  120. Driving cost factors in adult outpatients with refractory epilepsy: A daily clinical practice in clinics of neurology in Spain

    Article • Epilepsy Research, February 2009, Elsevier

    Dr Pedro Jesus Serrano-Castro

  121. Guía de práctica clínica de la Sociedad Andaluza de Epilepsia sobre profilaxis y tratamiento de las crisis epilépticas sintomáticas agudas

    Article • Revista de Neurología, January 2009, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  122. Guía de práctica clínica de consenso de la Sociedad Andaluza de Epilepsia sobre prescripción de fármacos antiepilépticos genéricos

    Article • Revista de Neurología, January 2009, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  123. Guía de práctica clínica de consenso de la Sociedad Andaluza de Epilepsia: recomendaciones terapéuticas ante una crisis epiléptica y en el estado epiléptico

    Article • Revista de Neurología, January 2009, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  124. Guía de práctica clínica de consenso de la Sociedad Andaluza de Epilepsia para el diagnóstico y tratamiento del paciente con una primera crisis epiléptica en situaciones de urgencia

    Article • Revista de Neurología, January 2009, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  125. Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: A cost-of-illness study (LINCE study)

    Article • Epilepsy Research, October 2008, Elsevier

    Dr Pedro Jesus Serrano-Castro

  126. Possible case of peripheral osmotic demyelination syndrome

    Article • Journal of Neurology Neurosurgery & Psychiatry, March 2008, BMJ

    Dr Pedro Jesus Serrano-Castro

  127. Incidencia de ictus en España. Bases metodológicas del estudio Iberictus

    Article • Revista de Neurología, January 2008, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  128. Pseudomigraña con pleocitosis y la ‘invisibilidad’ de las descripciones originales en castellano

    Article • Revista de Neurología, January 2008, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  129. Clinical Implications of Mechanisms of Resistance to Antiepileptic Drugs

    Article • The Neurologist, November 2007, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  130. Stiff person syndrome (SPS), a basal ganglia disease? Striatal MRI lesions in a patient with SPS

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2007, BMJ

    Dr Pedro Jesus Serrano-Castro

  131. Bilateral Bell Palsy and Acute HIV Type 1 Infection: Report of 2 Cases and Review

    Article • Clinical Infectious Diseases, March 2007, Oxford University Press (OUP)

    Dr Pedro Jesus Serrano-Castro

  132. Menstrual Tension-Type Headache: Evidence for Its Existence.

    Article • Headache The Journal of Head and Face Pain, January 2007, Wiley

    Dr Pedro Jesus Serrano-Castro

  133. A transcranial doppler study in interictal migraine and tension-type headache

    Article • Journal of Clinical Ultrasound, January 2007, Wiley

    Dr Pedro Jesus Serrano-Castro

  134. International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

    Article • JAMA, January 2006, American Medical Association (AMA)

    Professor Deepak L Bhatt, Dr Pedro Jesus Serrano-Castro, Professor Ron D. Hays, Professor Ivan G. Milanov, Professor Yuriy M. Sirenko

  135. Encefalomielitis aguda diseminada por picadura de himenóptero

    Article • Revista de Neurología, January 2006, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  136. Avances en el conocimiento de la etiología y la fisiopatología de las epilepsias reflejas

    Article • Revista de Neurología, January 2006, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  137. Cirugía de la epilepsia del lóbulo temporal: ¿es suficiente eliminar las crisis?

    Article • Revista de Neurología, January 2006, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  138. Trombólisis en el ictus: la accesibilidad sin garantía de seguridad es insostenible

    Article • Revista de Calidad Asistencial, December 2005, Elsevier

    Dr Pedro Jesus Serrano-Castro

  139. Regarding: 'Mosaicism and seizure onset in ring chromosome 20 syndrome'

    Article • Acta Neurologica Scandinavica, September 2005, Wiley

    Dr Pedro Jesus Serrano-Castro

  140. The Red Ear Syndrome: Five New Cases

    Article • Cephalalgia, June 2005, SAGE Publications

    Dr Pedro Jesus Serrano-Castro

  141. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: II. Terapéutica antiepiléptica crónica en el adulto y en el niño

    Article • Revista de Neurología, January 2005, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  142. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: III. Tratamiento antiepiléptico en situaciones especiales

    Article • Revista de Neurología, January 2005, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  143. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: I. Criterios de inicio y cese y bases farmacológicas del tratamiento antiepiléptico

    Article • Revista de Neurología, January 2005, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  144. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: IV. Principios generales de politerapia antiepiléptica y estrategias terapéuticas en epilepsia refractaria

    Article • Revista de Neurología, January 2005, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  145. Doppler transcraneal en el diagnóstico de fístula arteriovenosa pulmonar

    Article • Revista de Neurología, January 2005, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  146. Infarto maligno de la arteria cerebral media: ¿tratamiento médico o quirúrgico?

    Article • Revista de Neurología, January 2004, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  147. Hemorragia cerebral múltiple y antiagregantes plaquetarios

    Article • Revista de Neurología, January 2004, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  148. Ring chromosome 20 epilepsy syndrome in children: Electroclinical features

    Article • Neurology, March 2002, Wolters Kluwer Health

    Dr Pedro Jesus Serrano-Castro

  149. Paciente de 45 años con epilepsia refractaria del lóbulo temporal desde la infancia

    Article • Revista de Neurología, January 2002, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  150. Epilepsia refractaria del adulto

    Article • Revista de Neurología, January 2002, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  151. Comment: Fluorouracil-Induced Aphasia: Neurotoxicity versus Cerebral Ischemia

    Article • Annals of Pharmacotherapy, June 2001, SAGE Publications

    Dr Pedro Jesus Serrano-Castro

  152. Comment: fluorouracil-induced aphasia: neurotoxicity versus cerebral ischemia

    Article • Annals of Pharmacotherapy, June 2001, SAGE Publications

    Dr Pedro Jesus Serrano-Castro

  153. Epilepsia parcial refractaria a tratamiento médico y lesión porencefálica occipital

    Article • Revista Clínica Española, January 2001, Elsevier

    Dr Pedro Jesus Serrano-Castro

  154. Controversias en torno a los nuevos fármacos antiepilépticos

    Article • Revista de Neurología, January 2001, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  155. El diagnóstico de la enfermedad cervical espondilótica: una revisión basada en la evidencia

    Article • Revista de Neurología, January 2001, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  156. Caracterización epidemiológica de la epilepsia del adulto subsidiaria de ingreso hospitalario

    Article • Revista de Neurología, January 2001, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  157. Pseudotumor inflamatorio: diagnóstico diferencial de los tumores del IV ventrículo

    Article • Revista de Neurología, January 2001, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  158. Cromosoma 20 en anillo: ¿Una canalopatía epiléptica?

    Article • Revista de Neurología, January 2001, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  159. Ischemic Stroke following Cisplatin and 5-Fluorouracil Therapy: A Transcranial Doppler Study

    Article • European Neurology, January 2000, Karger Publishers

    Dr Pedro Jesus Serrano-Castro

  160. Descripción histórica de la asociación de macroorquídia, retraso mental y dismorfia craneal en varones (Síndrome del cromosoma X frágil) por A. B. Richerand

    Article • Revista de Neurología, January 2000, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  161. Hemodinámica cerebral en el síndrome de pseudomigraña con pleocitosis de LCR: un estudio Doppler transcraneal

    Article • Revista de Neurología, January 2000, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  162. El diagnóstico de la esclerosis temporal mesial mediante imagen de resonancia magnética

    Article • Revista de Neurología, January 2000, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  163. Correlación genotipo-fenotipo en la distrofia miotónica y predicción de la gravedad clínica

    Article • Revista de Neurología, January 1999, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  164. Hemiatrofia facial progresiva de Parry-Romberg: consideraciones patogénicas y evolutivas a propósito de un caso con seguimiento prolongado

    Article • Revista de Neurología, January 1999, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  165. Esclerosis temporal mesial (II): manifestaciones clínicas y estudios complementarios

    Article • Revista de Neurología, January 1998, Viguera Editores SLU

    Dr Pedro Jesus Serrano-Castro

  166. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases

    Article • Brain, July 1997, Oxford University Press (OUP)

    Dr Pedro Jesus Serrano-Castro

  167. Mediterranean spotted fever with central and peripheral neurological complications

    Article • European Journal of Neurology, January 1996, Wiley

    Dr Pedro Jesus Serrano-Castro